MACAU DAILY TIMES 澳門每日時報

Top Menu

  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia

Main Menu

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
logo
FOUNDER & PUBLISHER Kowie Geldenhuys
EDITOR-IN-CHIEF Paulo Coutinho
Macau,

MACAU DAILY TIMES 澳門每日時報

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • China-Russia-US Heads of State Declaration toward Peace

  • APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

  • Lawmakers call for stronger building management and measures to stabilize property market

  • Bill sets five grounds for dissolution of civil associations

  • Pansy Ho urges unified Greater Bay Area tourism strategy

  • Lawmakers get more speaking time under revised policy debate format

HeadlinesMacau
Home›Headlines›MUST to take breakthrough vaccine to human trials shortly

MUST to take breakthrough vaccine to human trials shortly

By -
Tuesday, August 4, 2020
168
0

The medical breakthrough announced by Macau University of Science and Technology (MUST) researchers this week could prove a major step forward in the development of a viable Covid-19 vaccine, according to the scientists behind the research.
The researchers found that administering a vaccine candidate on small mammals had offered potent protection from the virus, with none of the sampled animals developing any evidence of pneumonia.
The next step – to be initiated shortly, according to the researchers – will be to evaluate and validate the vaccine in human clinical trials.
The research team consists of researchers from MUST and the Hong Kong Polytechnic University (PolyU), in collaboration with other Chinese institutions, who jointly published a research paper in the prestigious science journal, Nature.
With this latest achievement, MUST and its research partners join a global effort to develop a vaccine to combat Covid-19.
According to data from the World Health Organization, there are more than 150 candidate Covid-19 vaccines under development around the world. The most prestigious medical and academic institutions are currently testing those vaccines and some have already started with human trials.
The MUST researchers say there is a credible threat of further outbreaks of the virus, “which may only stop once a vaccine is available to everyone.”

Professor Manson Fok, Dean of the Faculty of Medicine at MUST, confirmed yesterday that human clinical trials, the next step toward realizing the vaccine, would begin soon.
“Our research team has faced many challenges when designing our vaccine for best effect, while keeping side effects to a minimum and relieving other production concerns,” said Fok in prepared statements. “To move forward, the efficacy of the vaccine needs to be evaluated and validated in human clinical trials, which will be initiated shortly.”
“This breakthrough in Covid-19 vaccine could not have been achieved without the concerted efforts of our researchers and we hope mass vaccination can be conducted in the nearest future,” added Fok.
Dr Johnson Lau, adjunct professor of the Department of Applied Biology and Chemical Technology of PolyU, and Alexander Wai, deputy president and provost of PolyU, were among the other senior researchers involved in the collaboration.
Lau said that the vaccine was “expected to provide a practical solution to fight against Covid-19” because of its credible safety profile and “commercially feasible system,” which could “be used to manufacture the candidate vaccine, if successful, on a commercial scale.”
Alexander Wai described the vaccine as possible “the best vaccine choice to combat this pandemic.”
He said that it was the mission of the research team to “utilize scientific technologies for prevention and control of the virus, so as to help people to live under the ‘new normal’ of coronavirus.”
The research approach and methodology were explained in detail during an online press conference yesterday.
The researchers found that a recombinant vaccine comprising of a receptor-binding domain (RBD) induced a potent and functional antibody response in the immunized mice, rabbits and non-human primates (Macaca mulatta) as early as seven or 14 days after a single dose injection.
According to the researchers, the sera from the immunized animals neutralized infection by SARS-CoV-2.
Moreover, there is no evidence of antibody-dependent enhancement or acceleration of pneumonia in the mice or monkeys that received the vaccine, and none developed any evidence of pneumonia.
“The objective of this study was to evaluate the potential of a candidate vaccine based on the RBD domain of SARS-CoV-2,” said Professor Kang Zhang from the Faculty of Medicine of MUST, the corresponding author of the paper.
“At the same time, we wanted to evaluate the appropriate dosing regime, to test its effect in generating neutralizing activity against SARS-CoV-2 in the recipient animals and to determine the immune pathways involved in the generation of the immune response, so as to provide the groundwork for the design of an effective SARS-CoV-2 preventive vaccine,” explained Zhang.
“Our finding highlights the importance of the RBD domain in the SARS-CoV-2 vaccine design, which provides the rationale for the development of a protective vaccine through the induction of antibody against the RBD domain.” Daniel Beitler & Julie Zhu

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

Like this:

Like Loading…

Related

Previous Article

Briefs | Latest weather guidelines released for ...

Next Article

Asia Today: Manila back under lockdown as ...

Related articles More from author

  • HeadlinesMacau

    School principals ask for more sports fields

    Friday, January 20, 2017
    By -
  • HeadlinesMacau

    Energy | Nuclear accounts for 90% of Macau electricity supply

    Thursday, November 21, 2019
    By -
  • HeadlinesMacau

    One year later, Canidrome still waiting for better days

    Monday, July 15, 2019
    By Renato Marques, MDT
  • Asia-PacificHeadlines

    People chooses president in runoff amid political feud

    Wednesday, April 20, 2022
    By -
  • Macau

    New directors of DSI inaugurated

    Tuesday, March 21, 2023
    By -
  • Macau

    Opposition party won most seats in parliamentary election

    Wednesday, May 24, 2023
    By -

Leave a reply Cancel reply

You must be logged in to post a comment.

  • Macau

    GBA | Guangzhou office of B&R lawyers association opens doors

  • HeadlinesMacau

    Wanted: extension of economic housing applications, say lawmakers

  • Greater Bay

    Guangzhou: First train of the year to Europe

DAILY EDITION

Friday, November 20, 2026 – edition no. 5079
Friday, November 20, 2026 – edition no. 5079

Greater Bay

MDT MACAU GRAND PRIX SPECIAL

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Timeline

  • Friday, November 20, 2026

    China-Russia-US Heads of State Declaration toward Peace

  • Friday, November 20, 2026

    APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

  • Friday, November 20, 2026

    Lawmakers call for stronger building management and measures to stabilize property market

  • Friday, November 20, 2026

    Bill sets five grounds for dissolution of civil associations

  • Friday, November 20, 2026

    Pansy Ho urges unified Greater Bay Area tourism strategy

  • Friday, November 20, 2026

    Lawmakers get more speaking time under revised policy debate format

  • Friday, November 20, 2026

    Over 85% of resident owners say Iao Hon redevelopment cannot wait

  • Friday, November 20, 2026

    Porsche leads surprise charge in opening GT World Cup sessions

  • Friday, November 20, 2026

    Rivera leads provisional FR World Cup qualifying after crash-hit session

  • Friday, November 20, 2026

    Red flags interrupt F4 practice as Killion tops timesheets

Extra Times

Drive InExtra Times

‘Madden’ biopic can’t find a playbook to stick with

Which play to run is a question that can bedevil any football coach, and it’s also what dooms David O. Russell’s fumbled biopic “Madden.” “Madden” may sport an all-star cast ...
  • Juksunchae: A Study in Precision and Contemporary Korean Cuisine

    By Irene Sam, MDT
    Friday, November 20, 2026
  • Reframing the “Hundreds of Flavors”: Chiang and Ho at Zi Yat Heen

    By -
    Friday, November 20, 2026
  • Three chefs. One horizon. Six Michelin stars

    By Irene Sam, MDT
    Friday, November 13, 2026
  • James Gray delivers a milestone crime drama in ‘Paper Tiger’

    By MDT/AP
    Friday, November 13, 2026
  • Recent

  • Popular

  • China-Russia-US Heads of State Declaration toward Peace

    By XINHUA
    Friday, November 20, 2026
  • APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

    By Times Reporter
    Friday, November 20, 2026
  • Lawmakers call for stronger building management and measures to stabilize property market

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Bill sets five grounds for dissolution of civil associations

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Pansy Ho urges unified Greater Bay Area tourism strategy

    By Nadia Shaw, MDT
    Friday, November 20, 2026
  • Lawmakers get more speaking time under revised policy debate format

    By -
    Friday, November 20, 2026
  • Over 85% of resident owners say Iao Hon redevelopment cannot wait

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Canidrome may have its days numbered, decision in ‘one or two months’

    By Paulo Coutinho, MDT
    Thursday, May 26, 2016
  • Animal Welfare | Macau: Anima slams Canidrome management for avoiding debate

    By -
    Wednesday, May 4, 2016
  • Editorial | Canidoomed

    By Paulo Coutinho, MDT
    Wednesday, June 1, 2016
  • Animal Welfare | Canidrome presented with ultimatum: close or move

    By Daniel Beitler, MDT
    Friday, July 22, 2016
  • Australia regulator cracks down on alleged exportation of dogs to Macau

    By Paulo Coutinho, MDT
    Friday, June 10, 2016
  • Animal rights | Canidrome: Anima in fresh airline negotiations as Canidrome closure looks more likely

    By Daniel Beitler, MDT
    Friday, May 27, 2016
  • USE OF ENGLISH IN MACAU | A ‘de facto’ official language

    By Catarina Pinto
    Monday, July 6, 2015
  • Contact our Administrator
  • Contact our Editor-in-Chief
  • Contacts
  • Our Team
  • Privacy Policy
  • Terms and Conditions
  • Editorial Statute
  • Code of Ethics
COPYRIGHT © MACAU DAILY TIMES 2008-2026. ALL RIGHTS RESERVED
MACAU DAILY TIMES
  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
Loading Comments...

You must be logged in to post a comment.

%d